The Senate is short of the 60 votes it will need to pass a prescription drug pricing bill, Senate Finance Committee Chairman Charles Grassley (R-Iowa) said Nov. 21 at a forum sponsored by the Committee for a Responsible Federal Budget.
The bill (S. 2543), proposed by Sens. Grassley and Ron Wyden (D-Ore.), is the only bill in Congress that enjoys bipartisan support, he said. Drug pricing is one of the White House’s major priorities for the end of the year.
Grassley and Wyden expect to have an updated version of the bill “in the coming weeks.”